A judge in Texas has ordered Microsoft (MSFT) to stop selling some versions of its Word software in the United States within two months. This follows a May decision that found Word infringes on a Canadian tech firm's patent.

The offending programs are Word 2003 and Word 2007, which seem to have borrowed technology on how to encode and display information. In addition, MSFT was ordered to pay $290 million to the Canadian firm i4i for damages and interest. The judge also issued an injunction that will take effect in 60 days, this move will not allow MSFT to sell Word products including the patented technology.

Today was one of those days where stocks looked lower early in the morning, traded lower, and stayed there. Despite recovering from triple-digit losses in the DJIA earlier on, we still closed down 65.63 at 8.675.24 on the DJIA.

The S&P took a bigger hit by almost 13.00 at a lower level of 931.76. Bond prices rallied and we saw a 9 basis point drop in the 10-Year Treasury to 3.55%.

Here were today's top analyst upgrades, and there were several key downgrades as well.

Today was a day marked by selling, partly on economic news and partly on a call from S&P. S&P put the credit bias of the United Kingdom at "negative" from "stable" giving the notion that the nation's Triple-A ranking is possibly at risk to be cut. Then came the implications from Bill Gross and others that the U.S. could ultimately see the same fate. To show how bad the trend and bias was, long-dated Treasuries saw their yields rise as much as 15 basis points today.

A slightly less-bad jobs report failed to catch any attention today. In short, if you are a market bear you are getting more feathers in your cap now that earnings are basically finished. Here are today's unofficial closing bell levels:

Dow 8,291.82 -130.22 (-1.55%)
S&P 500 888.23 -15.24 (-1.69%)
Nasdaq 1,695.25 -32.59 (-1.89%)

Top Analyst Calls

Nintendo Co., Ltd. (ADR) (OTC: NTDOY)'s Wii game console continuet to burn up the sales charts, selling hundreds of thousands every month. In fact, the lower-priced and graphically-inferior Wii has blown through almost every sales expectation since its release nearly two years ago. Last month, the Wii was responsible for 49% of all game consoles, and it's sold nearly 30 million since its November 2006 launch. Wow.

But, with success comes a large target on the back. Nintendo has been named in a patent lawsuit claiming the Japanese gaming company. Hillcrest Technologies says that Nintendo has violated various patents it holds dealing with the wireless, dimension-aware gaming controller that ships with every Wii console.

The "Wiimote," as it has been dubbed, uses gyroscopes, Bluetooth wireless technology, and is incredibly simplistic on the surface (there are a minimum of buttons, unlike the competition). But inside the Wiimote, the technology making it possible to swing it like a tennis racket is quite complex. Hillcrest's claim rests primarily on wireless technology it invented to allow the physical motion of a controller to select items on a viewing monitor. Hillcrest has already licensed its technology to several gaming companies, but the question remains: why did it take almost two years to bring the lawsuit against Nintendo? Something smells here.

MAJOR PAPERS:

• This year, the International Trade Commission is set to issue rulings on whether Samsung and Nokia Corporation (NYSE: NOK) have infringed patents from InterDigital Inc (NASDAQ: IDCC). If InterDigital, who licenses its patents to iPhone maker Apple Inc (NASDAQ: AAPL), wins, fees from the deals could double its revenue over the next few years, the Wall Street Journal contended.
• The Wall Street Journal also reported that Macy's Inc (NYSE: M) is among the retailers that include The Home Depot Inc (NYSE: HD) and Sears Holdings Corporation (NASDAQ: SHLD) to stop making its monthly disclosure of retail sales.

OTHER PAPERS:

• According to FDA commissioners, the New York Times reported that Baxter International Inc's (NYSE: BAX) critical blood thinner heparin, which has been linked to nearly 20 deaths and whose base was created in China, contained a "possibly counterfeit" ingredient that "mimicked the real drug."
• In his opening arguments in the state of Alaska's lawsuit against Eli Lilly & Company (NYSE: LLY), an attorney for the state alleged the drug maker failed to warn doctors and patients of dangerous side effects associated with its drug Zyprexa, the Associated Press reported.